Freshpet, Inc. (FRPT): Results of Operations and Financial Condition
Freshpet, Inc. (FRPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Freshpet, Inc. Reports Second Quarter 2026 Financial Results Delivers ~15% Net Sales Growth Raises 2026 Net Sales and Adjusted EBITDA Outlook Updates Long-Term Adjusted Gross Margin Target to >49% Bedminster, N.J. – August 5, 2026 – Freshpet, Inc. (“Freshpet” or the
How this was made
The 30-second read
Why it matters
The key tradable items are the raised FY 2026 net sales growth and Adjusted EBITDA ranges, alongside Q2 gross margin and Adjusted EBITDA outperformance.
Market read
A guidance update with concrete ranges typically drives same-day repricing and sets expectations for the next earnings cycle.
What to watch
SG&A rose as a percent of sales in Q2 due to logistics costs and variable compensation accrual, which could pressure future operating leverage despite gross margin strength.
Freshpet reports 15.5% second-quarter net sales growth, expands gross margin, delivers higher Adjusted EBITDA, and raises full-year 2026 net sales and Adjusted EBITDA outlook.
Second-quarter net sales grew 15.5%, gross margin expanded to 42.1%, Adjusted EBITDA increased to $52.2 million, cash from operations rose for the six-month period, and the Company raised its 2026 net sales growth and Adjusted EBITDA guidance.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Second Quarter 2026 Net salesGAAP | $305.6 million | – | 15.5% |
| Second Quarter 2026 Volume gainsother | 15.7% | – | – |
| Second Quarter 2026 Price/mixother | unfavorable price/mix of 0.2% | – | – |
| Second Quarter 2026 Gross profitGAAP | $128.7 million | – | – |
| Second Quarter 2026 Gross marginGAAP | 42.1% | – | – |
| Second Quarter 2026 Adjusted Gross Profitnon-GAAP | $148.4 million | – | – |
| Second Quarter 2026 Adjusted Gross Marginnon-GAAP | 48.6% | – | – |
| Second Quarter 2026 Selling, general and administrative expensesGAAP | $107.0 million | – | – |
| Second Quarter 2026 SG&A as a percentage of net salesGAAP | 35.0% | – | – |
| Second Quarter 2026 Adjusted SG&Anon-GAAP | $96.1 million | – | – |
| Second Quarter 2026 Adjusted SG&A as a percentage of net salesnon-GAAP | 31.4% | – | – |
| Second Quarter 2026 Net incomeGAAP | $19.5 million | – | – |
| Second Quarter 2026 Adjusted EBITDAnon-GAAP | $52.2 million | – | – |
| First Six Months of 2026 Net salesGAAP | $603.2 million | – | 14.3% |
| First Six Months of 2026 Volume gainsother | 15.1% | – | – |
| First Six Months of 2026 Price/mixother | unfavorable price/mix of 0.8% | – | – |
| First Six Months of 2026 Gross profitGAAP | $249.4 million | – | – |
| First Six Months of 2026 Gross marginGAAP | 41.3% | – | – |
| First Six Months of 2026 Adjusted Gross Profitnon-GAAP | $288.0 million | – | – |
| First Six Months of 2026 Adjusted Gross Marginnon-GAAP | 47.7% | – | – |
| First Six Months of 2026 Selling, general and administrative expensesGAAP | $223.3 million | – | – |
| First Six Months of 2026 SG&A as a percentage of net salesGAAP | 37.0% | – | – |
| First Six Months of 2026 Adjusted SG&Anon-GAAP | $197.8 million | – | – |
| First Six Months of 2026 Adjusted SG&A as a percentage of net salesnon-GAAP | 32.8% | – | – |
| First Six Months of 2026 Net incomeGAAP | $68.0 million | – | – |
| First Six Months of 2026 Adjusted EBITDAnon-GAAP | $90.1 million | – | – |
| First Six Months of 2026 Free Cash Flownon-GAAP | $27.4 million | – | – |
| First Six Months of 2026 Cash from operationsGAAP | $84.8 million | – | an increase of $46.1 million |
| Cash and cash equivalents as of June 30, 2026GAAP | $350.8 million | increased $72.8 million | – |
| Debt outstanding as of June 30, 2026GAAP | $398.4 million | – | – |
full year 2026; full year 2027 outlook
- RevenueFull year 2026 net sales growth in the range of 10% to 12%; full year 2027 net sales well in excess of the category growth rate
- Gross marginFull year 2027 Adjusted Gross Margin of at least 49%
- NoteFull year 2026 Adjusted EBITDA in the range of $210 million to $220 million
- NoteFull year 2026 Positive Free Cash Flow with capital expenditures of ~$150 million
- NoteFull year 2027 Adjusted EBITDA margin in the range of 20% to 22%
Capital returns
- $54.4 million of share repurchases pursuant to the previously announced share repurchase program.
What drove it
- Second-quarter net sales growth was primarily driven by volume gains of 15.7%, partially offset by unfavorable price/mix of 0.2%.
- First-six-month net sales growth was primarily driven by volume gains of 15.1%, partially offset by unfavorable price/mix of 0.8%.
- Gross profit margin increased due to lower input costs and improved leverage on plant expenses, partially offset by higher quality costs related to the startup of new technology lines.
- Second-quarter Adjusted EBITDA increased as a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.
- Six-month net income benefited from the gain on equity investment following the sale of 100% of the Company's non-controlling interest in a privately held company following its acquisition by a third party.
Concerns
- Second-quarter SG&A as a percentage of net sales increased to 35.0% from 34.1%, primarily due to increased logistics costs and variable compensation accrual.
- Higher quality costs related to the startup of new technology lines partially offset gross-margin improvement.
- Price/mix was unfavorable in both the second quarter and first six months of 2026.
- The Company cited economic uncertainty, competitive products, tariffs, fuel, energy and ingredient pricing, media effectiveness, new-chiller success rates, and implementation of new technologies among risks to forward-looking expectations.
What to watch
- Whether volume gains continue to outweigh unfavorable price/mix.
- The impact of new technology-line startup costs and quality costs on gross-margin progression.
- Logistics costs and variable compensation accruals, which increased SG&A pressure in the second quarter.
- Execution against full-year 2026 net sales growth of 10% to 12%, Adjusted EBITDA of $210 million to $220 million, positive Free Cash Flow, and capital expenditures of ~$150 million.
- Progress toward the full-year 2027 Adjusted Gross Margin target of at least 49% and Adjusted EBITDA margin target of 20% to 22%.
Balance sheet and cash flow
- As of June 30, 2026, cash and cash equivalents were $350.8 million.
- Debt outstanding was $398.4 million, net of $4.1 million of unamortized debt issuance costs.
- Cash and cash equivalents increased $72.8 million compared to $278.0 million as of December 31, 2025.
- The Company received $100.0 million of cash proceeds from the sale of its equity investment.
- For the six months ended June 30, 2026, cash from operations was $84.8 million, an increase of $46.1 million compared to the prior year period.
- Free Cash Flow was $27.4 million for the six months ended June 30, 2026.
Analysis
Freshpet delivered second-quarter net sales of $305.6 million, up 15.5% from $264.7 million in the prior-year period. Growth was volume-led, with volume gains of 15.7%, while price/mix was unfavorable by 0.2%. For the first six months, net sales rose 14.3% to $603.2 million, supported by volume gains of 15.1% and partially offset by unfavorable price/mix of 0.8%.
Profitability improved at the gross-profit level. Second-quarter gross margin rose to 42.1% from 40.9%, and Adjusted Gross Margin increased to 48.6% from 46.9%. The Company attributed the improvement to lower input costs and better leverage on plant expenses, partly offset by higher quality costs associated with startup of new technology lines. First-six-month gross margin similarly increased to 41.3% from 40.2%, while Adjusted Gross Margin rose to 47.7% from 46.3%.
SG&A remained an area of attention. Second-quarter SG&A increased to $107.0 million, or 35.0% of net sales, from $90.4 million, or 34.1% of net sales, reflecting increased logistics costs and variable compensation accrual. Adjusted SG&A also rose as a share of sales to 31.4% from 30.1%. Nevertheless, higher Adjusted Gross Profit supported second-quarter Adjusted EBITDA of $52.2 million versus $44.4 million in the prior-year period. Net income was $19.5 million versus $16.4 million, with the increase also benefiting from an additional gain on the equity investment.
Cash generation strengthened over the six-month period. Cash from operations was $84.8 million, an increase of $46.1 million compared with the prior-year period, and Free Cash Flow was $27.4 million. Cash and cash equivalents reached $350.8 million as of June 30, 2026, while debt outstanding was $398.4 million, net of $4.1 million of unamortized debt issuance costs. The Company received $100.0 million of proceeds from its equity-investment sale and used $54.4 million for share repurchases.
Management raised full-year 2026 net sales growth guidance to 10% to 12% from 8% to 11% and raised Adjusted EBITDA guidance to $210 million to $220 million from $205 million to $215 million. Positive Free Cash Flow and capital expenditures of ~$150 million were unchanged. For 2027, Freshpet increased its Adjusted Gross Margin target to at least 49% from at least 48%, while retaining its expectation for net sales well in excess of category growth and an Adjusted EBITDA margin of 20% to 22%.
Management, verbatim
Our second quarter performance demonstrates the strength and resilience of our business model. It also reinforces our belief that fresh is the future of pet food and that Freshpet is uniquely positioned to win in that segment.
Billy Cyr, Chief Executive Officer
Despite economic headwinds and new competitors, we grew significantly faster than the category, improved margins, and produced strong cash flow.
Billy Cyr, Chief Executive Officer
Not in the filing
stated, not guessed- GAAP operating income for the second quarter of 2026 and prior-year period.
- GAAP operating income for the first six months of 2026 and prior-year period.
- GAAP diluted EPS and non-GAAP diluted EPS.
- Income tax rate.
- Free Cash Flow for the prior-year six-month period.
- Capital expenditures incurred during the second quarter or first six months of 2026.
- Cash from operations for the prior-year six-month period.
- Segment revenue disclosure.
- Prior-quarter comparisons for reported income-statement metrics.
- Dividend information.
- Separate previous outlook section for comparison of actual results against prior guidance.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Freshpet filed an 8-K with Q2 2026 financial results and updated full-year 2026 outlook, including margin and cash flow commentary.
Ticker impact
Freshpet reported Q2 2026 results and raised full-year 2026 net sales growth to 10% to 12% and Adjusted EBITDA to $210M to $220M.
Bias upward on open, with follow-through risk if investors focus on SG&A deleveraging or non-GAAP adjustments.
The filing discloses specific Q2 metrics (net sales +15.5%, gross margin 42.1%) and explicit updated FY 2026 ranges, which are direct inputs to valuation and positioning.
Market effects
Pet food manufacturers may see read-across demand and margin expectations if Freshpet’s volume growth and gross margin trend is viewed as durable.
Limited direct regional spillover; primarily US-listed consumer/retail sentiment.
Low global relevance beyond broader pet food demand and input-cost narrative.
Counterpoint
Investors may discount the guidance raise if they believe margin gains are partly driven by temporary input-cost relief and new line startup costs.
Key entities
- companyFreshpet, Inc.
Nasdaq-listed pet food manufacturer reporting Q2 2026 results and updating FY 2026 guidance.
- executiveBilly Cyr
CEO quoted on resilience, margin improvement, and confidence in long-term value creation.
